Thomas McFarlane
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in ⓘ
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- William Wong (5 shared papers)Stephen Tully (4 shared papers)Kelvin Chan (4 shared papers)Yasmeen Razvi (3 shared papers)John J. Kim (1 shared paper)Erin McKenzie (3 shared papers)Edward Chow (3 shared papers)Carlo DeAngelis (3 shared papers)
- Journals
- Supportive Care in Cancer (4 papers)The Oncologist (2 papers)American Journal of Pharmaceutical Education (1 paper)PharmacoEconomics (1 paper)Future Oncology (1 paper)
- Partner nations
- CanadaSwedenUnited States
In The Last Decade
Thomas McFarlane
19 papers receiving 299 citations
Peers
Comparison fields: 5 of 76
- Hepatology 42
- Oncology 125
- Otorhinolaryngology 14
- Surgery 108
- Complementary and alternative medicine 15
Countries citing papers authored by Thomas McFarlane
This map shows the geographic impact of Thomas McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas McFarlane more than expected).
Fields of papers citing papers by Thomas McFarlane
This network shows the impact of papers produced by Thomas McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas McFarlane. The network helps show where Thomas McFarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas McFarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 104 | |
| 2 | 2019 | 53 | |
| 3 | 2017 | 35 | |
| 4 | 2019 | 23 | |
| 5 | 2019 | 17 | |
| 6 | 2020 | 10 | |
| 7 | 2018 | 10 | |
| 8 | 2019 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2019 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 1 |
About Thomas McFarlane
Thomas McFarlane is a scholar working on Geriatrics and Gerontology, Family Practice, Oncology, Anesthesiology and Pain Medicine and Internal Medicine, having authored 19 papers that have together received 303 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Nausea and vomiting management (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Anesthesia and Pain Management (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Anesthesia and Sedative Agents (2 papers). The work is most often cited by research in Hepatology (42 citations), Oncology (125 citations), Otorhinolaryngology (14 citations), Surgery (108 citations) and Complementary and alternative medicine (15 citations). Thomas McFarlane has collaborated with scholars based in Canada, Sweden and United States. Frequent co-authors include William Wong, Stephen Tully, Kelvin Chan, Yasmeen Razvi, John J. Kim, Erin McKenzie, Edward Chow, Carlo DeAngelis, Pearl Zaki and Stephanie Chan. Their work appears in journals such as Supportive Care in Cancer, The Oncologist, American Journal of Pharmaceutical Education, PharmacoEconomics and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.